DbVisualizer is a universal database client for anyone who works with data, from indie developers and startups to professional teams managing complex database environments, including developers, DBAs, analysts, and data engineers working across relational and NoSQL databases.
Key features:
- SQL editor with intelligent autocomplete, visual query builders, variables, and execution tools
- AI Assistant for answering questions, explaining errors, and analyzing code
- Git integration for managing SQL scripts and team collaboration
- Customizable layouts, key bindings, and UI themes
- Favorites for frequently used scripts and database objects
- Configurable security settings for organizational requirements
Connects via JDBC to MySQL, PostgreSQL, SQL Server, Oracle, Snowflake, SQLite, Cassandra, BigQuery, and more. Runs on Windows, macOS, and Linux.
Nearly 7 million downloads, with Pro users in 150 countries, scaling from solo projects to enterprise database management.
Learn more
Foxit delivers a robust set of cloud-native APIs that enable organizations to automate and modernize document-driven workflows at scale. Built on flexible REST architecture, these APIs allow developers to seamlessly create, convert, extract, sign, and display documents within their own applications—improving efficiency while reducing manual processes.
The Foxit PDF Services API handles large-scale PDF processing, including conversion, extraction, optimization, and redaction. The Document Generation API streamlines the production of personalized PDFs and DOCX files using dynamic templates and live business data. The Foxit eSign API integrates secure, legally binding eSignature workflows with audit tracking and compliance capabilities. The PDF Embed API provides customizable in-app document viewing with support for annotations, forms, and secure user access.
Combined, Foxit APIs give enterprises a secure and scalable platform for digital document automation and workflow transformation.
Learn more
VeraChem
Founded in 2000, VeraChem LLC aims to enhance the field of computer-aided drug discovery and molecular design by creating advanced computational chemistry techniques that merge innovative basic science with practical applications in research. A key aspect of the company's strategy for product development lies in delivering efficient, high-performance software solutions along with extensive user support. Among the current capabilities of VeraChem's software are predictions for protein-ligand and host-guest binding affinities, rapid and precise calculations of partial atomic charges for drug-like molecules, and the computation of energies and forces utilizing widely-used empirical force fields. Additionally, the software features automatic generation of alternate resonance forms for drug-like compounds, a robust conformational search enabled by the Tork algorithm, and the automatic identification of topological and three-dimensional molecular symmetries. The modular code base of VeraChem’s software packages allows for flexibility and adaptability in meeting diverse research needs, ensuring that users can leverage these tools effectively for their specific applications.
Learn more
3decision
3decision® serves as a cloud-based repository for protein structures, focusing on efficient management of structural data and offering sophisticated analytics to support teams involved in the discovery of small molecules and biologics, thereby expediting the process of structure-based drug design.
The platform consolidates and standardizes both experimental and computational protein structures sourced from publicly available databases such as RCSB PDB and AlphaFoldDB, in addition to proprietary datasets, and accommodates formats like PDBx/mmCIF and ModelCIF. This comprehensive approach guarantees seamless access to a variety of structural formats including X-Ray, NMR, cryo-EM, and modeled structures, thereby promoting collaboration and bolstering research initiatives.
In addition to its storage capabilities, 3decision® enhances each entry with valuable metadata and sequence information, which encompasses details on protein-ligand interactions, antibody annotations, and specifics about binding sites. Equipped with advanced analytical instruments, the platform is capable of pinpointing druggable sites, evaluating off-target risks, and facilitating comparisons of binding sites, which collectively transform extensive structural datasets into practical insights that can drive research forward.
Furthermore, its cloud-based architecture fosters enhanced collaboration among research teams, making it easier for scientists to share findings and insights, ultimately leading to more innovative approaches in drug discovery and development.
Learn more